Clifford Chance

Clifford Chance advises Deutsche Bank on the sale of Actavis to Watson Pharmaceuticals

Leading international law firm Clifford Chance is advising Deutsche Bank on the restructuring and sale of the Swiss drug maker to Watson Pharmaceuticals for up to €4.5 billion ($5.9 billion).

The Clifford Chance team is being led by Corporate partners Mark Poulton and Joel Ziff, with tax advice from Dan Neidle.